Status:
NOT_YET_RECRUITING
The Young Adults' Experiences With Virtual Reality (YAES VR) Study
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Population Health
Eligibility:
All Genders
18-24 years
Phase:
NA
Brief Summary
The purpose of this study is to test the effect of virtual reality (VR) food marketing exposure (versus VR non-food control) on snack consumption, purchase intention, hunger, and arousal in black and ...
Detailed Description
Food marketing has been unequivocally linked to poor diet and risk of excessive weight gain in young people. Food companies disproportionately target Black consumers with more advertisements ("ads") a...
Eligibility Criteria
Inclusion
- 18-24 years old;
- self-identify as Black or white in order to determine racial/ethnic differences in responses to unhealthy VR-based food and beverage marketing;
- self-report normal or corrected-to-normal vision from glasses or contacts;
- self-report comfort and ability to walk around within a VR paradigm;
- able to read, write, understand, and respond to all study materials (including the VR paradigm) in English
- residing in the NYC-metropolitan area in order to be available for in-person study
- capacity and willingness to provide consent
Exclusion
- report a history of disorders causing motion sickness or have a history of significant motion sickness, which could be triggered within the VR paradigm
- self-report dietary restriction, such as food allergies or veganism, which may lead to different effects when exposed to food marketing;
- Self-report disliking 50% or more of the snacks that will be offered during the laboratory test snack as determined by a score of 5 or less on the food preferences questionnaire, which may have a confounding effect on consumption;
- report being pregnant or breastfeeding, which may affect hunger;
- smoke or consume tobacco, which decreases salivary flow; or
- self-report being very hungry based on 100 mm VAS hunger rating, which minimizes the burden to participants to fast prior to the visit and maximizes the ability to detect differences between groups.Those excluded for being very hungry will have the option of returning to the visit on a different day.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06917391
Start Date
April 1 2025
End Date
March 31 2028
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016